Marker Therapeutics Inc (MRKR)

[BluMarlin1960]

Lets hope they use their cash to expedite, the her2Nue phase 11 trial, by 1st quarter of 2016 it would be great to have minimum 2 phase 11 trials in Multi Billion dollar markets.

Now the FDA approval process for "fast tracking" the Folate receptor may be a much simpler and expedited process.

Tapimmune is really beginning to get the validation they deserve.

2016 looks like a very good year.

GLTA

BLU